A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT00861874 · COMPLETED
Trial details
- NCT number
- NCT00861874
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2012-09-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.